ID   PLK3_HUMAN              Reviewed;         646 AA.
AC   Q9H4B4; Q15767; Q5JR99; Q96CV1;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 2.
DT   02-NOV-2010, entry version 100.
DE   RecName: Full=Serine/threonine-protein kinase PLK3;
DE            EC=2.7.11.21;
DE   AltName: Full=Cytokine-inducible serine/threonine-protein kinase;
DE   AltName: Full=FGF-inducible kinase;
DE   AltName: Full=Polo-like kinase 3;
DE            Short=PLK-3;
DE   AltName: Full=Proliferation-related kinase;
GN   Name=PLK3; Synonyms=CNK, FNK, PRK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Embryo;
RX   MEDLINE=20493044; PubMed=11039900; DOI=10.1038/sj.onc.1203845;
RA   Holtrich U., Wolf G., Yuan J., Bereiter-Hahn J., Karn T., Weiler M.,
RA   Kauselmann G., Rehli M., Andreesen R., Kaufmann M., Kuhl D.,
RA   Strebhardt K.;
RT   "Adhesion induced expression of the serine/threonine kinase Fnk in
RT   human macrophages.";
RL   Oncogene 19:4832-4839(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SER-61; PHE-68;
RP   PHE-283; CYS-483; LEU-498 AND PRO-618.
RG   NIEHS SNPs program;
RL   Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ASN-491.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 28-646.
RC   TISSUE=Placenta;
RX   MEDLINE=96325053; PubMed=8702627; DOI=10.1074/jbc.271.32.19219;
RA   Li B., Ouyang B., Pan H., Reissmann P.T., Slamon D.J., Arceci R.,
RA   Lu L., Dai W.;
RT   "Prk, a cytokine-inducible human protein serine/threonine kinase whose
RT   expression appears to be down-regulated in lung carcinomas.";
RL   J. Biol. Chem. 271:19402-19408(1996).
RN   [7]
RP   CHARACTERIZATION.
RX   MEDLINE=98019242; PubMed=9353331; DOI=10.1074/jbc.272.45.28646;
RA   Ouyang B., Pan H., Lu L., Li J., Stambrook P., Li B., Dai W.;
RT   "Human Prk is a conserved protein serine/threonine kinase involved in
RT   regulating M phase functions.";
RL   J. Biol. Chem. 272:28646-28651(1997).
RN   [8]
RP   CHARACTERIZATION.
RX   MEDLINE=20027391; PubMed=10557092; DOI=10.1038/sj.onc.1202983;
RA   Ouyang B., Li W., Pan H., Meadows J., Hoffmann I., Dai W.;
RT   "The physical association and phosphorylation of Cdc25C protein
RT   phosphatase by Prk.";
RL   Oncogene 18:6029-6036(1999).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-348, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
CC   -!- FUNCTION: Serine/threonine protein kinase involved in regulating M
CC       phase functions during the cell cycle. May also be part of the
CC       signaling network controlling cellular adhesion. In vitro, is able
CC       to phosphorylate CDC25C and casein.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Binds to the calcium/integrin-binding protein (CIB). This
CC       interaction probably occurs via the POLO-box domain.
CC   -!- INTERACTION:
CC       P04156:PRNP; NbExp=2; IntAct=EBI-751877, EBI-977302;
CC       Q99986:VRK1; NbExp=6; IntAct=EBI-751877, EBI-1769146;
CC   -!- SUBCELLULAR LOCATION: Membrane; Peripheral membrane protein.
CC   -!- TISSUE SPECIFICITY: Transcripts are highly detected in placenta,
CC       lung, followed by skeletal muscle, heart, pancreas, ovaries and
CC       kidney and weakly detected in liver and brain. May have a short
CC       half-live. In cells of hematopoietic origin, strongly and
CC       exclusively detected in terminally differentiated macrophages.
CC       Transcript expression appears to be down-regulated in primary lung
CC       tumor.
CC   -!- INDUCTION: Cytokine and cellular adhesion trigger FNK induction.
CC   -!- PTM: Phosphorylated as cells enter mitosis and dephosphorylated as
CC       cells exit mitosis (By similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. CDC5/Polo subfamily.
CC   -!- SIMILARITY: Contains 2 POLO box domains.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC50637.1; Type=Erroneous initiation;
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/plk3/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ293866; CAC10659.1; -; mRNA.
DR   EMBL; AY764184; AAU88146.1; -; Genomic_DNA.
DR   EMBL; AL592166; CAI13006.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07021.1; -; Genomic_DNA.
DR   EMBL; BC013899; AAH13899.1; -; mRNA.
DR   EMBL; U56998; AAC50637.1; ALT_INIT; mRNA.
DR   IPI; IPI00304186; -.
DR   RefSeq; NP_004064.2; -.
DR   UniGene; Hs.632415; -.
DR   ProteinModelPortal; Q9H4B4; -.
DR   SMR; Q9H4B4; 52-329, 458-642.
DR   IntAct; Q9H4B4; 20.
DR   MINT; MINT-110679; -.
DR   STRING; Q9H4B4; -.
DR   PRIDE; Q9H4B4; -.
DR   Ensembl; ENST00000372201; ENSP00000361275; ENSG00000173846.
DR   GeneID; 1263; -.
DR   KEGG; hsa:1263; -.
DR   UCSC; uc001cmn.1; human.
DR   CTD; 1263; -.
DR   GeneCards; GC01P045265; -.
DR   H-InvDB; HIX0199969; -.
DR   HGNC; HGNC:2154; PLK3.
DR   MIM; 602913; gene.
DR   PharmGKB; PA26664; -.
DR   eggNOG; prNOG10409; -.
DR   HOGENOM; HBG738952; -.
DR   HOVERGEN; HBG001843; -.
DR   InParanoid; Q9H4B4; -.
DR   OMA; PRSGRTY; -.
DR   OrthoDB; EOG9NW252; -.
DR   PhylomeDB; Q9H4B4; -.
DR   BRENDA; 2.7.11.21; 247.
DR   NextBio; 5111; -.
DR   ArrayExpress; Q9H4B4; -.
DR   Bgee; Q9H4B4; -.
DR   CleanEx; HS_PLK3; -.
DR   Genevestigator; Q9H4B4; -.
DR   GermOnline; ENSG00000173846; Homo sapiens.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042801; F:polo kinase kinase activity; IEA:InterPro.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; TAS:ProtInc.
DR   InterPro; IPR020636; Ca/CaM-dep_prot_kinase-like.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000959; POLO_box_duplicated_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   InterPro; IPR015728; Ser/Thr_prot_kinase_Polo-like.
DR   PANTHER; PTHR22982; Ca/CaM-dep_prot_kinase-like; 1.
DR   PANTHER; PTHR22982:SF10; Polo-like_kinase; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00659; POLO_box; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50078; POLO_BOX; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Kinase; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Repeat; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    646       Serine/threonine-protein kinase PLK3.
FT                                /FTId=PRO_0000086564.
FT   DOMAIN       62    314       Protein kinase.
FT   DOMAIN      470    537       POLO box 1.
FT   DOMAIN      567    637       POLO box 2.
FT   NP_BIND      68     76       ATP (By similarity).
FT   ACT_SITE    185    185       Proton acceptor (By similarity).
FT   BINDING      91     91       ATP (By similarity).
FT   MOD_RES     348    348       Phosphothreonine.
FT   VARIANT      61     61       T -> S (in dbSNP:rs17884581).
FT                                /FTId=VAR_021091.
FT   VARIANT      68     68       L -> F (in dbSNP:rs17884316).
FT                                /FTId=VAR_021092.
FT   VARIANT     283    283       L -> F (in dbSNP:rs17880471).
FT                                /FTId=VAR_021093.
FT   VARIANT     483    483       R -> C (in dbSNP:rs17884653).
FT                                /FTId=VAR_021094.
FT   VARIANT     491    491       D -> N (in dbSNP:rs17855444).
FT                                /FTId=VAR_062384.
FT   VARIANT     498    498       S -> L (in dbSNP:rs17880829).
FT                                /FTId=VAR_021095.
FT   VARIANT     618    618       S -> P (in dbSNP:rs17881786).
FT                                /FTId=VAR_021096.
FT   CONFLICT     16     16       A -> T (in Ref. 1; CAC10659).
FT   CONFLICT     20     20       P -> T (in Ref. 1; CAC10659).
FT   CONFLICT     99     99       A -> V (in Ref. 1; CAC10659).
FT   CONFLICT    353    353       G -> V (in Ref. 1; CAC10659).
FT   CONFLICT    419    419       D -> H (in Ref. 1; CAC10659).
FT   CONFLICT    464    470       VSKWVDY -> FSEWVGF (in Ref. 1; CAC10659).
FT   CONFLICT    522    522       P -> R (in Ref. 1; CAC10659).
SQ   SEQUENCE   646 AA;  71629 MW;  324CA3E9DE482514 CRC64;
     MEPAAGFLSP RPFQRAAAAP APPAGPGPPP SALRGPELEM LAGLPTSDPG RLITDPRSGR
     TYLKGRLLGK GGFARCYEAT DTETGSAYAV KVIPQSRVAK PHQREKILNE IELHRDLQHR
     HIVRFSHHFE DADNIYIFLE LCSRKSLAHI WKARHTLLEP EVRYYLRQIL SGLKYLHQRG
     ILHRDLKLGN FFITENMELK VGDFGLAARL EPPEQRKKTI CGTPNYVAPE VLLRQGHGPE
     ADVWSLGCVM YTLLCGSPPF ETADLKETYR CIKQVHYTLP ASLSLPARQL LAAILRASPR
     DRPSIDQILR HDFFTKGYTP DRLPISSCVT VPDLTPPNPA RSLFAKVTKS LFGRKKKSKN
     HAQERDEVSG LVSGLMRTSV GHQDARPEAP AASGPAPVSL VETAPEDSSP RGTLASSGDG
     FEEGLTVATV VESALCALRN CIAFMPPAEQ NPAPLAQPEP LVWVSKWVDY SNKFGFGYQL
     SSRRVAVLFN DGTHMALSAN RKTVHYNPTS TKHFSFSVGA VPRALQPQLG ILRYFASYME
     QHLMKGGDLP SVEEVEVPAP PLLLQWVKTD QALLMLFSDG TVQVNFYGDH TKLILSGWEP
     LLVTFVARNR SACTYLASHL RQLGCSPDLR QRLRYALRLL RDRSPA
//
